Table Info

Table 1.

Main characteristics of the PLAs studied with CEUS^*

Demographic characteristics	PLAs values
No patients	44
No male/female	24/20
Mean age (years ± SD)	66 ± 14.7
No PLAs	44
Mean size (cm ± SD)	6.8 ± 3.2
Site right/left	28/16
Etiology
Neoplasia (colon/pancreas/biliary tract)	2/4/4
Acute calculous cholecystitis	8
Choledocholithiasis	7
Intrahepatic lithiasis	3
Post-surgery	6
Idiopathic	5
Diverticulitis	2
Diabetes	2
Foreign body	1
Symptoms
Fever > 38°C	40
Jaundice	11
Abdominal pain	35
Malaise	8

In 8 patients with multiple PLA only the largest one was studied with CEUS. SD: standard deviation

Declarations

Author contributions

The author contributed solely to the work.

Conflicts of interest

The author declares that he has no conflicts of interest.

Ethical approval

The study was approved by Pineta Grande Hospital Institutional Ethic Committee.

Consent to participate

A written informed consent was obtained from all the patients at the time of admission, with which the tissue, blood and other samples might be used for scientific research but did not relate to patient’s privacy.

Consent to publication

Not applicable.

Availability of data and materials

The data analyzed in this study was obtained from Pineta Grande Hospital. Requests for access to these datasets should be directed to archivio@pinetagrande.it.

Funding

Not applicable.

Copyright

References

Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier-Saunders; 2015. [DOI]

Chiche L, Dargère S, Le Pennec V, Dufay C, Alkofer B. Abcès à pyogènes du foie. Diagnostic et prise en charge [Pyogenic-liver abscess: diagnosis and management]. Gastroenterol Clin Biol. 2008;32:1077–91. French. [DOI] [PubMed]

Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Liver abscesses and hydatid disease. BMJ. 2001;322:537–40. [DOI] [PubMed] [PMC]

Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, Dixon E, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol. 2010;105:117–24. [DOI] [PubMed]

Sharma A, Mukewar S, Mara KC, Dierkhising RA, Kamath PS, Cummins N. Epidemiologic factors, clinical presentation, causes, and outcomes of liver abscess: a 35-year Olmsted County study. Mayo Clin Proc Innov Qual Outcomes. 2018;2:16–25. [DOI] [PubMed] [PMC]

Cerwenka H. Pyogenic liver abscess: differences in etiology and treatment in Southeast Asia and Central Europe. World J Gastroenterol. 2010;16:2458–62. [DOI] [PubMed] [PMC]

Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012;12:881–7. [DOI] [PubMed]

Lardière-Deguelte S, Ragot E, Amroun K, Piardi T, Dokmak S, Bruno O, et al. Hepatic abscess: diagnosis and management. J Visc Surg. 2015;152:231–43. [DOI] [PubMed]

Mukthinuthalapati VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, Araujo T, Gandhi S. Risk factors, management, and outcomes of pyogenic liver abscess in a US safety net hospital. Dig Dis Sci. 2020;65:1529–38. [DOI] [PubMed]

10.

Lai HC, Lin CC, Cheng KS, Kao JT, Chou JW, Peng CY, et al. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Gastroenterology. 2014;146:129–37.e1. [DOI] [PubMed]

11.

Halvorsen RA, Korobkin M, Foster WL, Silverman PM, Thompson WM. The variable CT appearance of hepatic abscesses. AJR Am J Roentgenol. 1984;142:941–6. [DOI] [PubMed]

12.

Lin AC, Yeh DY, Hsu YH, Wu CC, Chang H, Jang TN, et al. Diagnosis of pyogenic liver abscess by abdominal ultrasonography in the emergency department. Emerg Med J. 2009;26:273–5. [DOI] [PubMed]

13.

Mortelé KJ, Segatto E, Ros PR. The infected liver: radiologic-pathologic correlation. Radiographics. 2004;24:937–55. [DOI] [PubMed]

14.

Benedetti NJ, Desser TS, Jeffrey RB. Imaging of hepatic infections. Ultrasound Q. 2008;24:267–78. [DOI] [PubMed]

15.

Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound Med Biol. 2020;46:2579–604. [DOI] [PubMed]

16.

Catalano O, Sandomenico F, Raso MM, Siani A. Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. AJR Am J Roentgenol. 2004;182:447–50. [DOI] [PubMed]

17.

Catalano O, Sandomenico F, Nunziata A, Raso MM, Vallone P, Siani A. Transient hepatic echogenicity difference on contrast-enhanced ultrasonography: sonographic sign and pitfall. J Ultrasound Med. 2007;26:337–45. [DOI] [PubMed]

18.

Xie L, Guang Y, Ding H, Cai A, Huang Y. Diagnostic value of contrast-enhanced ultrasound, computed tomography, and magnetic resonance imaging for focal liver lesions: a meta-analysis. Ultrasound Med Biol. 2011;37:854–61. [DOI] [PubMed]

19.

Kishina M, Koda M, Tokunaga S, Miyoshi K, Fujise Y, Kato J, et al. Usefulness of contrast-enhanced ultrasound with Sonazoid for evaluating liver abscess in comparison with conventional B-mode ultrasound. Hepatol Res. 2015;45:337–42. [DOI] [PubMed]

20.

vanSonnenberg E, Wittich GR, Goodacre BW, Casola G, D’Agostino HB. Percutaneous abscess drainage: update. World J Surg. 2001;25:362–9. [DOI] [PubMed]

21.

Trillos-Almanza MC, Restrepo Gutierrez JC. How to manage: liver abscess. Frontline Gastroenterol. 2020;12:225–31. [DOI] [PubMed] [PMC]

22.

Pang TC, Fung T, Samra J, Hugh TJ, Smith RC. Pyogenic liver abscess: an audit of 10 years’ experience. World J Gastroenterol. 2011;17:1622–30. [DOI] [PubMed] [PMC]

23.

Alkofer B, Dufay C, Parienti JJ, Lepennec V, Dargere S, Chiche L. Are pyogenic liver abscesses still a surgical concern? A Western experience. HPB Surg. 2012;2012:316013. [DOI] [PubMed] [PMC]

24.

Kunze G, Staritz M, Köhler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol. 2015;41:952–9. [DOI] [PubMed]

25.

Morita M, Ogawa C, Omura A, Noda T, Kubo A, Matsunaka T, et al. The efficacy of Sonazoid-enhanced ultrasonography in decision-making for liver abscess treatment. Intern Med. 2020;59:471–7. [DOI] [PubMed] [PMC]

26.

Francica G, Meloni MF, de Sio I, Terracciano F, Caturelli E, Riccardi L, et al. Biopsy of liver target lesions under contrast-enhanced ultrasound guidance—a multi-center study. Ultraschall Med. 2018;39:448–53. [DOI] [PubMed] [PMC]

27.

Francica G, Meloni MF, Riccardi L, de Sio I, Terracciano F, Caturelli E, et al. Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study. Eur J Radiol. 2018;105:96–101. [DOI] [PubMed]

28.

Huang DY, Yusuf GT, Daneshi M, Ramnarine R, Deganello A, SellarsME, et al. Contrast-enhanced ultrasound (CEUS) in abdominal intervention. Abdom Radiol (NY). 2018;43:960–76. [DOI] [PubMed] [PMC]

29.

Francica G. Intracavitary contrast-enhanced ultrasound in ultrasound-guided percutaneous management of abdominal fluid collections/abscesses by a single clinician: an example of point-of-care ultrasound. J Ultrasound. 2020;23:175–81. [DOI] [PubMed] [PMC]